← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2005Last known activity
Sep 14, 2020
Timeline
1890s
- Jan 1, 1893
Mercy Medical Center— Founded
Drugs by trial phase (16 distinct, 8 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Appendiceal Neoplasms
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Communicable Diseases
- Cystadenocarcinoma
- Diabetes Mellitus, Type 2
- Diverticulitis
- Fallopian Tube Neoplasms
- Fibrosis
- Hepatitis
- Hepatitis B
- Infections
- Liver Cirrhosis
- Liver Diseases
- Metabolic Syndrome
- Ovarian Neoplasms
- Postoperative Pain
- Pseudomyxoma Peritonei
- Respiratory Tract Infections
- Syndrome
- Ureaplasma Infections
- Weight Loss
Recent trials (15)
- NCT04588077Lead sponsorPhase 4Sep 14, 2020
- NCT04588077Reponsible party - principal investigatorPhase 4Sep 14, 2020
- NCT04588077Overall official - principal investigatorPhase 4Sep 14, 2020
- NCT03976973CollaboratorPhase 1/Phase 2Jul 31, 2019
- NCT03657407Lead sponsorPhase 4Jun 1, 2016
- NCT03657407Sponsor investigatorPhase 4Jun 1, 2016
- NCT02387203Overall official - principal investigatorPhase 2Jan 1, 2015
- NCT02387203Lead sponsorPhase 2Jan 1, 2015
- NCT02124421Overall official - principal investigatorPhase 2Apr 1, 2014
- NCT02124421Lead sponsorPhase 2Apr 1, 2014
- NCT01778634CollaboratorPhase 2Jul 1, 2013
- NCT01778634Overall official - principal investigatorPhase 2Jul 1, 2013
- NCT02052557Overall official - principal investigatorPhase 4Feb 1, 2013
- NCT02052557CollaboratorPhase 4Feb 1, 2013
- NCT00243984CollaboratorPhase 3Mar 1, 2005
Details
- Founded
- Des Moines, IA, US Jan 1, 1893
- Last known activity
- Sep 14, 2020